课题基金 / 基金详情

The characterization and therapeutic targeting of metabolic and inflammatory signaling in chronic lymphedema

The characterization and therapeutic targeting of metabolic and inflammatory signaling in chronic lymphedema
慢性淋巴水肿代谢和炎症信号传导的特征和治疗靶向
批准号:
437630
负责人:
Liu Fei-Fei
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2021-10-01

项目摘要

项目成果

Liu Fei-Fei的其他基金

相似基金

相关文献

中文摘要
翻译
淋巴管是人体两个重要的循环系统之一。当淋巴管系统被堵塞时,液体会在组织中积聚,造成肿胀和疤痕。高达五分之一的癌症患者有淋巴水肿症
英文摘要
The lymphatics are one of two essential circulatory systems present throughout the human body. When the lymphatic vessel system is blocked, fluid accumulates in tissues causing swelling and scarring. Up to 1 in 5 cancer patients have lymphedema as a side
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The characterization and therapeutic targeting of aberrant metabolic and inflammatory signaling in chronic lymphedema
Seeking Molecular Signatures for Nasopharyngeal Carcinoma
  • 批准号:
    354751
  • 项目类别:
    Operating Grants
  • 资助金额:
    $83.6万
  • 财政年份:
    2016
  • 负责人:
    Liu Fei-Fei
  • 依托单位:
Seeking Molecular Signatures for Nasopharyngeal Carcinoma
  • 批准号:
    351842
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Liu Fei-Fei
  • 依托单位:
Discovery and Characterization of UROD Inhibitors for Cancer Therapy
  • 批准号:
    266442
  • 项目类别:
    Operating Grants
  • 资助金额:
    $33.33万
  • 财政年份:
    2012
  • 负责人:
    Liu Fei-Fei
  • 依托单位:
海外基金